In that trial, investigators are testing whether the drug can reduce the risk of all-cause mortality, nonfatal MI, nonfatal stroke, coronary revascularization, or heart failure events in patients with overweight and established cardiovascular disease (or multiple risk factors based on age)
This means the medication may become less effective or stop working entirely
When you sign up (for as little as $5/month), you get access to *all* WH+ membership benefits , including: A years worth of health programming, from nutrition guides to targeted workout plans, all created by WH editors and experts Exclusive fitness challenges, including the popular and Glute Gains Challenge Ultimate Pull-Up Plan 450+ streaming workouts with 1 year of our All Out Studio fitness app (a $90 value) Hundreds of easy, healthy recipes, plus our High-Protein Meal Prep Manual Unlimited WomensHealthMag.com content and a one-year print magazine subscription Cori Ritchey, C.S.C.S., is the fitness editor at Women's Health , as well as a certified strength and condition coach and group fitness instructor
Which patients are most likely to see lower inflammation
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation